Literature DB >> 11855739

Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failure.

M Chmielewski1, T Nieweglowski, J Swierczynski, B Rutkowski, W Boguslawski.   

Abstract

Changes in lipid metabolism are an important risk factor for vascular complications during chronic renal failure (CRF). In experimental CRF hypercholesterolemia has been found to be the main lipid disorder. It is probably due to enhanced cholesterologenesis. Mechanisms of these changes remain poorly understood. It is well known that activity of cholesterologenesis undergoes a significant diurnal rhythm. However, there was no evidence that this rhythm is still present in the course of experimental CRF. Results of our studies indicate that in contrast to puromycin induced nephrotic syndrome, diurnal rhythm of cholesterologenesis in CRF rats is preserved both in liver and in the intestine tissue. Significant higher incorporation of tritiated water into cholesterol fraction was found in vivo both in liver as well as in intestine of CRF rats, as compared to control animals. Increased (with comparison to the controls) incorporation of 14C-acetate, and 3H-mevalonate into CRF rat liver sterols indicate that mechanism of enhanced cholesterologenesis is more complex than simply due to the elevated level of mevalonate (potential substrate for cholesterologenesis) which has been reported in plasma of CRF animals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11855739     DOI: 10.1023/a:1013395921241

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  18 in total

1.  Decreased albuminuria by pravastatin in hyperlipidemic diabetics.

Authors:  T Shoji; Y Nishizawa; A Toyokawa; T Kawagishi; Y Okuno; H Morii
Journal:  Nephron       Date:  1991       Impact factor: 2.847

2.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

3.  Partial remission of nephrotic syndrome in patient on long-term simvastatin.

Authors:  A J Rabelink; R J Hené; D W Erkelens; J A Joles; H A Koomans
Journal:  Lancet       Date:  1990-04-28       Impact factor: 79.321

4.  Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.

Authors:  B L Kasiske; M P O'Donnell; W J Garvis; W F Keane
Journal:  Circ Res       Date:  1988-02       Impact factor: 17.367

Review 5.  Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review.

Authors:  Z H Beg; J A Stonik; H B Brewer
Journal:  Metabolism       Date:  1987-09       Impact factor: 8.694

6.  The diurnal variation of hepatic HMG-CoA reductase activity is due to changes in the level of immunoreactive protein.

Authors:  G C Ness; C M Chambers
Journal:  Arch Biochem Biophys       Date:  1996-03-01       Impact factor: 4.013

7.  Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7 alpha-hydroxylase in rats with subtotal nephrectomy.

Authors:  W M Pandak; Z R Vlahcevic; D M Heuman; R J Krieg; J D Hanna; J C Chan
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

8.  Low leptin mRNA level in adipose tissue and normoleptinemia in experimental chronic renal failure.

Authors:  J Swierczynski; J Korczynska; M Szolkiewicz; J Karbowska; Z Kochan; T Nieweglowski; E Kusiak; B Rutkowski
Journal:  Exp Nephrol       Date:  2001

9.  Evaluation of serum lipid abnormalities in chronic nephritis.

Authors:  H Hirano; Y Yamada; H Otani; N Kodama; M Mune; S Yukawa
Journal:  Kidney Int Suppl       Date:  1999-07       Impact factor: 10.545

10.  Downregulation of atrial natriuretic factor clearance receptors in experimental chronic renal failure rats.

Authors:  J K Luk; E F Wong; N L Wong
Journal:  Am J Physiol       Date:  1995-09
View more
  1 in total

1.  Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure.

Authors:  Michal Chmielewski; Elzbieta Sucajtys; Julian Swierczynski; Boleslaw Rutkowski; Wojciech Bogusławski
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.